BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8906812)

  • 21. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity.
    Watanabe R; Ishiura N; Nakashima H; Kuwano Y; Okochi H; Tamaki K; Sato S; Tedder TF; Fujimoto M
    J Immunol; 2010 May; 184(9):4801-9. PubMed ID: 20368271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse.
    Saito E; Fujimoto M; Hasegawa M; Komura K; Hamaguchi Y; Kaburagi Y; Nagaoka T; Takehara K; Tedder TF; Sato S
    J Clin Invest; 2002 Jun; 109(11):1453-62. PubMed ID: 12045259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation.
    Sato S; Steeber DA; Tedder TF
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11558-62. PubMed ID: 8524803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD19 can regulate B lymphocyte signal transduction independent of complement activation.
    Hasegawa M; Fujimoto M; Poe JC; Steeber DA; Tedder TF
    J Immunol; 2001 Sep; 167(6):3190-200. PubMed ID: 11544305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BAFF-driven autoimmunity requires CD19 expression.
    Fairfax KA; Tsantikos E; Figgett WA; Vincent FB; Quah PS; LePage M; Hibbs ML; Mackay F
    J Autoimmun; 2015 Aug; 62():1-10. PubMed ID: 26103922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD19 function in early and late B cell development. II. CD19 facilitates the pro-B/pre-B transition.
    Otero DC; Rickert RC
    J Immunol; 2003 Dec; 171(11):5921-30. PubMed ID: 14634103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD19 function in early and late B cell development: I. Maintenance of follicular and marginal zone B cells requires CD19-dependent survival signals.
    Otero DC; Anzelon AN; Rickert RC
    J Immunol; 2003 Jan; 170(1):73-83. PubMed ID: 12496385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule.
    Engel P; Zhou LJ; Ord DC; Sato S; Koller B; Tedder TF
    Immunity; 1995 Jul; 3(1):39-50. PubMed ID: 7542548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative genetic variation in CD19 expression correlates with autoimmunity.
    Sato S; Hasegawa M; Fujimoto M; Tedder TF; Takehara K
    J Immunol; 2000 Dec; 165(11):6635-43. PubMed ID: 11086109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD19(+)CD1d(+)CD5(+) B cell frequencies are increased in patients with tuberculosis and suppress Th17 responses.
    Zhang M; Zheng X; Zhang J; Zhu Y; Zhu X; Liu H; Zeng M; Graner MW; Zhou B; Chen X
    Cell Immunol; 2012; 274(1-2):89-97. PubMed ID: 22361174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of murine B cell subpopulations.
    Hardy RR
    Semin Immunol; 1990 May; 2(3):197-206. PubMed ID: 1717054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The tetraspanin CD81 regulates the expression of CD19 during B cell development in a postendoplasmic reticulum compartment.
    Shoham T; Rajapaksa R; Boucheix C; Rubinstein E; Poe JC; Tedder TF; Levy S
    J Immunol; 2003 Oct; 171(8):4062-72. PubMed ID: 14530327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD19 is a central response regulator of B lymphocyte signaling thresholds governing autoimmunity.
    Sato S
    J Dermatol Sci; 1999 Dec; 22(1):1-10. PubMed ID: 10651223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Siglec-G regulates B1 cell survival and selection.
    Jellusova J; Düber S; Gückel E; Binder CJ; Weiss S; Voll R; Nitschke L
    J Immunol; 2010 Sep; 185(6):3277-84. PubMed ID: 20729333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-cell maturation and antibody responses in individuals carrying a mutated CD19 allele.
    Artac H; Reisli I; Kara R; Pico-Knijnenburg I; Adin-Çinar S; Pekcan S; Jol-van der Zijde CM; van Tol MJ; Bakker-Jonges LE; van Dongen JJ; van der Burg M; van Zelm MC
    Genes Immun; 2010 Oct; 11(7):523-30. PubMed ID: 20445561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-Abl-deficient mice exhibit reduced numbers of peritoneal B-1 cells and defects in BCR-induced B cell activation.
    Liberatore RA; Goff SP
    Int Immunol; 2009 Apr; 21(4):403-14. PubMed ID: 19228876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Origins and functions of B-1 cells with notes on the role of CD5.
    Berland R; Wortis HH
    Annu Rev Immunol; 2002; 20():253-300. PubMed ID: 11861604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development.
    Zhou LJ; Smith HM; Waldschmidt TJ; Schwarting R; Daley J; Tedder TF
    Mol Cell Biol; 1994 Jun; 14(6):3884-94. PubMed ID: 7515149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD19 function in central and peripheral B-cell development.
    Del Nagro CJ; Otero DC; Anzelon AN; Omori SA; Kolla RV; Rickert RC
    Immunol Res; 2005; 31(2):119-31. PubMed ID: 15778510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A c-Myc and surface CD19 signaling amplification loop promotes B cell lymphoma development and progression in mice.
    Poe JC; Minard-Colin V; Kountikov EI; Haas KM; Tedder TF
    J Immunol; 2012 Sep; 189(5):2318-25. PubMed ID: 22826319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.